Physician

Erin Elizabeth Roesch, M.D.

According to 2025 Medicare claims, Erin Roesch, M.D. (NPI: 1336464262) practices hematology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44195-0001. Roesch is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Roesch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 154 traditional Medicare patients, billed 590 HCPCS/CPT codes, and received $31,001 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 555 prescription claims across 120 beneficiaries totaling $1,168,903 in drug costs, led by Kisqali (Ribociclib Succinate). DME data shows 33 claims. Open Payments data shows 23 records totaling $86,290. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,477 to $31,001. Similarly, Part D prescription costs have risen steadily, from $308 to $1,168,903. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$20K$39K2016 Medicare payment: $4,477 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $15,679 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $16,372 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $15,826 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $16,483 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $39,122 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $25,545 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $30,013 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $31,001 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20162140$4,477
201755190$15,679
201877264$16,372
201994282$15,826
2020100231$16,483
2021166491$39,122
2022137337$25,545
2023143400$30,013
2024154590$31,001

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$584K$1.2M2016 Drug cost: $308 (USD; Tot_Drug_Cst)2017 Drug cost: $18,891 (USD; Tot_Drug_Cst)2018 Drug cost: $132,513 (USD; Tot_Drug_Cst)2019 Drug cost: $85,968 (USD; Tot_Drug_Cst)2020 Drug cost: $170,869 (USD; Tot_Drug_Cst)2021 Drug cost: $447,398 (USD; Tot_Drug_Cst)2022 Drug cost: $297,098 (USD; Tot_Drug_Cst)2023 Drug cost: $708,206 (USD; Tot_Drug_Cst)2024 Drug cost: $1,168,903 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R23$308
201741203$18,891
201860315$132,513
201966352$85,968
202078247$170,869
2021104455$447,398
202297409$297,098
2023104461$708,206
2024120555$1,168,903

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.0K$2.0K2021 Medicare payment: $2,020 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,049 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R27$2,020
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R33$1,049

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more2222$133
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more78153$72
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes2164$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5163$42
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's110190$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KisqaliRibociclib Succinate34931$577,987
IbrancePalbociclib23644$353,602
TalzennaTalazoparib Tosylate12360$130,313
AnastrozoleAnastrozole20312,194$3,110
ExemestaneExemestane241,380$3,030

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R19$785
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R14$263

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$6,662TerSera Therapeutics LLC
Research PaymentsReported research-related payment or transfer-of-value amount.14$79,629Stemline Therapeutics Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Erin Elizabeth Roesch, M.D.?

Tedicare shows public-source Medicare data for Erin Elizabeth Roesch, M.D. (NPI 1336464262), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Erin Elizabeth Roesch, M.D. have ACO affiliation data?

Erin Elizabeth Roesch, M.D. is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to Erin Elizabeth Roesch, M.D.?

Erin Elizabeth Roesch, M.D. is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does Erin Elizabeth Roesch, M.D. have Open Payments data?

Erin Elizabeth Roesch, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.